RCS - GenIP PLC - GenIP to Sponsor the AUTM 2025 Annual Meeting

GenipAnnouncement

11/02/2025 07:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250211:nRSK5630Wa&default-theme=true

RNS Number : 5630W  GenIP PLC  11 February 2025

 

 

 

 

11 February 2025

 

 

GenIP Plc

("GenIP" or the "Company")

 

GenIP Plc to Sponsor the AUTM 2025 Annual Meeting

 

GenIP plc, a technology business providing Generative Artificial Intelligence
(GenAI) services to help research organisations and corporations commercialise
their innovations, is delighted to announce its sponsorship and participation
in the AUTM 2025 Annual Meeting, taking place from 2(nd) to 5(th) March 2025,
in Maryland, USA.

 

AUTM, formerly known as the Association of University Transfer Managers, is a
community of more than 3,000 members working in more than 800 universities,
research centres, hospitals, businesses and government organisations around
the globe.  AUTM is the leader in efforts to educate, promote and inspire
professionals to support the development of academic research and innovation.
This premier industry event is the world's largest gathering of technology
transfer professionals from around the world, fostering collaboration,
deal-making, and the exchange of insights on innovation and commercialisation.

 

The AUTM 2025 Annual Meeting is a key component of GenIP's broader marketing
strategy. This event builds on GenIP's recent sponsorship of other impactful
events, such as the XVIII National Brazilian Forum of Innovation and
Technology Transfer Managers (FORTEC) and a major innovation event hosted by a
leading research institution in Singapore, where GenIP forged relationships
that have already translated into orders from new clients.

 

The AUTM Annual Meeting, and its other US based regional meetings throughout
2025, offer a unique opportunity to further expand GenIP's network and connect
with influential professionals from both academia and industry. GenIP's
presence at AUTM will play a vital role in driving  long-term growth and
reinforcing GenIP's position as a leader in technology commercialisation.

 

Melissa Cruz, CEO of GenIP, commented:

 

"We are excited to be part of AUTM in 2025 and look forward to engaging with
leaders in technology transfer. It's an incredible opportunity to showcase how
GenIP's solutions are helping drive the commercialisation of groundbreaking
technologies that have the potential to positively impact lives around the
world."

 

Casey Annunziata, Business Development Manager of AUTM, commented:

 

"We are pleased to welcome GenIP as a sponsor at AUTM 2025. Their innovative
approach to technology commercialisation and commitment to advancing the
impact of emerging technologies align perfectly with our mission to foster
collaboration and drive progress in the technology transfer community."

 

About the AUTM 2025 Annual Meeting

 

The AUTM Annual Meeting is a leading global platform for advancing knowledge
in Intellectual Property, Technology Transfer, and Innovation. With over 9,000
face-to-face meetings and more than 90 educational sessions, this event plays
a pivotal role in strengthening the technology transfer ecosystem by
connecting professionals from universities, research institutions,
corporations, and investment firms.

 

Learn more about the AUTM Annual Meeting here: https://autm.net/2025/home
(https://autm.net/2025/home)

 

 

For further information regarding GenIP, please visit www.genip.ai
(http://www.genip.ai/) , or contact:

 

 GenIP Plc                                  Via Redchurch Communications

 Melissa Cruz, CEO

 Redchurch Communications (Financial PR)    genip@weareredchurch.com (mailto:genip@weareredchurch.com)

 John Casey

This is a Reach announcement. Reach is an investor communication service aimed
at assisting listed and unlisted (including AIM quoted) companies to
distribute media only / non-regulatory news releases into the public domain.
Information required to be notified under the AIM Rules for Companies, Market
Abuse Regulation or other regulations would be disseminated as an RNS
regulatory announcement and not on Reach.

 

 

Notes to Editors

 

About GenIP

 

GenIP provides generative artificial intelligence (GenAI) analytic services to
help companies, research institutions and venture funds assess and
commercialise new discoveries. GenIP combines expert human technical review
with GenAI algorithms to provide insightful and verified services.

 

GenIP provides two complementary platform-based services:

1.   Invention Evaluator: Provides bespoke research reports that assess the
market potential of new technological innovations and discoveries using
AI-driven proprietary software; and

 

2.   Vortechs: which is an executive recruitment platform that through
advanced machine learning algorithms and natural language processing
technologies assists in matching technology organisations with experienced
executives skilled in technology commercialisation.

 

The Company believes that its integrated GenAI service offerings will help
organisations to evaluate and commercialise their technological innovations.

Company Strategy

GenIP's goal is to be a leading Generative AI analytic services company. To
achieve this, the Company has established three strategic pillars:

 

●     Organically grow Invention Evaluator and Vortechs' revenue through
institutional and corporate connections as well as increase client pipeline
through marketing, advertising and social media spend.

●     Expand the Generative AI service offerings within Invention
Evaluator and Vortechs' to reach new customers and improve margins.

●     Bolt-on acquisitions of additional Generative AI services that are
helpful to our clients and have demonstrated initial market traction.

 

Forward looking statements

 

Certain statements contained in this announcement constitute forward-looking
statements. When used in this announcement, the words "may", "would", "could",
"will", "intend", "plan", "anticipate", "believe", "seek", "propose",
"estimate", "expect", and similar expressions, as they relate to the Company,
are intended to identify forward-looking statements. These statements include,
but are not limited to, statements regarding intentions, beliefs or current
expectations concerning, among other things, the Company's results of
operations, financial position, liquidity, prospects, growth, strategies and
expectations of the industry in which the Company operates.

 

Such statements reflect the Company's current views with respect to future
events and are subject to certain risks, uncertainties and assumptions. Many
factors could cause the Company's actual results, performance or achievements
to materially differ from those described in this announcement Should one or
more of these risks or uncertainties materialise, or should assumptions
underlying forward-looking statements prove incorrect, actual results may
differ materially from those described in this announcement as "intended",
"planned", "anticipated", "believed", "proposed", "estimated" or "expected".

 

For the avoidance of doubt, the contents of the Company's website and any
hyperlinks accessible from the Company's website are not incorporated by
reference into, and do not form part of, this announcement and investors
should not rely on them.

-ENDS-

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAFLFVSFIIILIE